CATALAYER NEWS

Processa Pharma president of R&D David Young buys $4,588 in stock

Source: Investing.com · 2026-06-16

Full article text is available in the Catalayer news terminal.

MORE FROM INVESTING.COM
Berenberg downgrades Cognizant as AI risks cloud IT services outlook
2026-06-17
Trump says will discuss with Gulf nations Iran’s ballistic missiles, terrorist proxies
2026-06-17
Form 8K Helios Technologies Inc For: 17 June
2026-06-17
Form 8K Alaska Air For: 17 June
2026-06-17
Qualitest rebrands as QualityAI, shifts focus to AI assurance
2026-06-17
RELATED ON CATALAYER
Related Topics
Biotech & FDA News
RELATED MARKETS
Prediction Markets
New Rihanna Album before GTA VI?52%New Playboi Carti Album before GTA VI?52%Will Jesus Christ return before GTA VI?50%
Open Catalayer terminal for live tracking →